BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22154485)

  • 1. Expression of TNKS1 is correlated with pathologic grade and Wnt/β-catenin pathway in human astrocytomas.
    Tang B; Wang J; Fang J; Jiang B; Zhang M; Wang Y; Yang Z
    J Clin Neurosci; 2012 Jan; 19(1):139-43. PubMed ID: 22154485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas.
    Sareddy GR; Panigrahi M; Challa S; Mahadevan A; Babu PP
    Neurochem Int; 2009 Sep; 55(5):307-17. PubMed ID: 19576519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L; Wang X; Jia T; Wei W; Chua MS; So S
    Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of frizzled 9 in astrocytomas.
    Zhang Z; Schittenhelm J; Guo K; Bühring HJ; Trautmann K; Meyermann R; Schluesener HJ
    Neuropathol Appl Neurobiol; 2006 Dec; 32(6):615-24. PubMed ID: 17083476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tankyrase Sterile α Motif Domain Polymerization Is Required for Its Role in Wnt Signaling.
    Riccio AA; McCauley M; Langelier MF; Pascal JM
    Structure; 2016 Sep; 24(9):1573-81. PubMed ID: 27499439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter methylation of WNT inhibitory factor-1 and expression pattern of WNT/β-catenin pathway in human astrocytoma: pathologic and prognostic correlations.
    Kim SA; Kwak J; Nam HY; Chun SM; Lee BW; Lee HJ; Khang SK; Kim SW
    Mod Pathol; 2013 May; 26(5):626-39. PubMed ID: 23328978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-cadherin, beta-catenin and connexin 43 expression in astrocytic tumours of various grades.
    Reszec J; Szkudlarek M; Hermanowicz A; Bernaczyk PS; Mariak Z; Chyczewski L
    Histol Histopathol; 2015 Mar; 30(3):361-71. PubMed ID: 25386667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for tankyrases as antineoplastic targets in lung cancer.
    Busch AM; Johnson KC; Stan RV; Sanglikar A; Ahmed Y; Dmitrovsky E; Freemantle SJ
    BMC Cancer; 2013 Apr; 13():211. PubMed ID: 23621985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nuclear beta-catenin localization is not sufficient for canonical Wnt signaling activation in human meianoma cell lines].
    Kulikova KV; Posviatenko AV; Gnuchev NV; Georgiev GP; Kibardin AV; Larin SS
    Mol Biol (Mosk); 2011; 45(5):884-91. PubMed ID: 22393786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased β-catenin/Tcf signaling in pilocytic astrocytomas: a comparative study to distinguish pilocytic astrocytomas from low-grade diffuse astrocytomas.
    Sareddy GR; Geeviman K; Panigrahi M; Challa S; Mahadevan A; Babu PP
    Neurochem Res; 2012 Jan; 37(1):96-104. PubMed ID: 21922255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase.
    Koirala S; Klein J; Zheng Y; Glenn NO; Eisemann T; Fon Tacer K; Miller DJ; Kulak O; Lu M; Finkelstein DB; Neale G; Tillman H; Vogel P; Strand DW; Lum L; Brautigam CA; Pascal JM; Clements WK; Potts PR
    Cell Rep; 2020 Jul; 32(3):107922. PubMed ID: 32698014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
    Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F
    Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas.
    Maris C; Rorive S; Sandras F; D'Haene N; Sadeghi N; Bièche I; Vidaud M; Decaestecker C; Salmon I
    Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological Functions of TNKS1 and Its Relationship with Wnt/β-Catenin Pathway in Astrocytoma.
    Chen M; Tang B; Xie S; Yan J; Yang L; Zhou X; Zeng E
    Onco Targets Ther; 2019; 12():10841-10850. PubMed ID: 31849489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear phosphorylated Y142 β-catenin accumulates in astrocytomas and glioblastomas and regulates cell invasion.
    Náger M; Santacana M; Bhardwaj D; Valls J; Ferrer I; Nogués P; Cantí C; Herreros J
    Cell Cycle; 2015; 14(22):3644-55. PubMed ID: 26654598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of thyroid hormone receptor isoforms in human astrocytomas.
    Hwang SL; Lin CL; Lieu AS; Hwang YF; Howng SL; Hong YR; Chang DS; Lee KS
    Surg Neurol; 2008 Dec; 70 Suppl 1():S1:4-8; discussion S1:8. PubMed ID: 18617237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines.
    Jingushi K; Takahashi-Yanaga F; Yoshihara T; Shiraishi F; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
    Biochem Pharmacol; 2012 Jan; 83(1):47-56. PubMed ID: 22005519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pinworm and TNKS inhibitors, an eccentric duo to derail the oncogenic WNT pathway.
    Ouelaa-Benslama R; Emami S
    Clin Res Hepatol Gastroenterol; 2011 Sep; 35(8-9):534-8. PubMed ID: 21782548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moesin is a glioma progression marker that induces proliferation and Wnt/β-catenin pathway activation via interaction with CD44.
    Zhu X; Morales FC; Agarwal NK; Dogruluk T; Gagea M; Georgescu MM
    Cancer Res; 2013 Feb; 73(3):1142-55. PubMed ID: 23221384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of fibroblast growth factor receptors (FGFRs) mRNA in human astrocytomas].
    Yamada SM; Bruner JM; Berger MS; Morrison RS
    No To Shinkei; 1996 Apr; 48(4):363-70. PubMed ID: 8679334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.